Detalhe da pesquisa
1.
Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B.
J Hepatol
; 79(1): 50-60, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-36893853
2.
Functional reconstitution of HBV-specific CD8 T cells by in vitro polyphenol treatment in chronic hepatitis B.
J Hepatol
; 74(4): 783-793, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33188902
3.
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.
Gastroenterology
; 157(1): 227-241.e7, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30930022
4.
HBV Immune-Therapy: From Molecular Mechanisms to Clinical Applications.
Int J Mol Sci
; 20(11)2019 Jun 05.
Artigo
Inglês
| MEDLINE | ID: mdl-31195619
5.
The Good and the Bad of Natural Killer Cells in Virus Control: Perspective for Anti-HBV Therapy.
Int J Mol Sci
; 20(20)2019 Oct 13.
Artigo
Inglês
| MEDLINE | ID: mdl-31614928
6.
Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches.
Front Immunol
; 11: 849, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32477347
7.
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection.
Nat Commun
; 11(1): 604, 2020 01 30.
Artigo
Inglês
| MEDLINE | ID: mdl-32001678
8.
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B.
Nat Med
; 23(3): 327-336, 2017 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-28165481